CRO/CMO concept experiences a volatile surge, ChemPartner hits the "20cm" limit up
The concept of CRO/CMO has fluctuated and surged, with ChemPartner hitting the "20cm" limit up, followed by gains in PHARMABLOCK, HITECK, Jiuzhou Pharma, Tigermed, JOINN, and Nossan
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments